US5871909A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Human cellular retinoic acid binding protein I and II DNA and methods of use
Assignee: University of Michigan (System)
•
Filing: 1994-05-11
•
Granted: 1999-02-16
•
Expires: 2014-05-11
Abstract
Abstract The sequences encoding two isoforms of human cellular retinoid acid binding proteins, CRABP-I and CRABP-II, have been cloned and sequenced and are set forth with their corresponding amino acid sequences. The identification of human CRABP nucleic and amino acid sequences provides the basis for the construction of recombinant human CRABP vectors and expression constructs. Human CRABP can also be synthesized or produced ex vivo, e.g. in bacterial or other production systems. Ligand binding assays, including recombinant and chimeric receptor reporter assays, and direct and competition hybridization assays employing the human CRABP sequences herein described can be used to test drugs for retinoid induction and tissue specificity for pathologies in which retinoids are implicated. Immunoassays utilizing antibodies or binding fragments produced to human CRABP can also be used to test patient tissues for the presence and levels of CRABP for diagnosis and to monitor treatment. The identification of the nucleic and amino acids sequences for human CRABP-I and CRABP-II also contributes to the elucidation of the function and interaction of the retinoid-binding proteins.
Inventors
- 👤 Anders Åstrom
- 👤 John J. Voorhees
- 👤 Ulrika Pettersson
- 👤 Amir Tavakkol
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 03:56
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/705; C07K14/70567; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6897; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/566; G01N33/68; G01N33/6872; G01N2333/00; G01N2333/435; G01N2333/705; G01N2333/70567; G01N2500/00
Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
36 words
An isolated nucleic acid which hybridizes under stringent conditions with the full length complement of the nucleotide sequence set forth as SEQ ID NO:6, wherein the nucleic acid encodes human cellular retinoic acid binding protein-II (CRABP-II).
Claim 2
Dependent Claim
36 words
An isolated nucleic acid which hybridizes under stringent conditions with the full length complement of the nucleotide sequence set forth as SEQ ID NO:6, wherein the nucleic acid encodes human cellular retinoic acid binding protein-II (CRABP-II).
Claim 3
Dependent Claim
11 words
The nucleic acid of claim 1, which is a ribonucleic acid.
Claim 4
Dependent Claim
17 words
The nucleic acid of claim 1, which comprises the nucleotide sequence set forth as SEQ ID NO:6.
Claim 5
Dependent Claim
19 words
An isolated nucleic acid which hybridizes under stringent conditions with the nucleotide sequence set forth as SEQ ID NO:6.
Claim 6
Dependent Claim
19 words
An isolated nucleic acid which hybridizes under stringent conditions with the nucleotide sequence set forth as SEQ ID NO:6.
Claim 7
Dependent Claim
11 words
The nucleic acid of claim 4, which is a ribonucleic acid.
Claim 8
Dependent Claim
22 words
The nucleic acid of claim 4, which comprises the full length complement of the nucleotide sequence set forth as SEQ ID NO:6.
Claim 9
Independent Claim
81 words
A method of screening a sample for expression of human CRABP-II comprising the steps of: a) contacting the sample to a nucleic acid probe which hybridizes under stringent conditions to the nucleotide sequence set forth as SEQ ID NO:1, wherein the nucleotide sequence is a ribonucleic acid and the contacting occurs under the stringent conditions; and b) detecting whether hybridization occurs between the nucleic acid probe and the sample, wherein detection of said hybridization indicates that the sample expresses human CRABP-II.
Claim 10
Independent Claim
81 words
A method of screening a sample for expression of human CRABP-II comprising the steps of: a) contacting the sample to a nucleic acid probe which hybridizes under stringent conditions to the nucleotide sequence set forth as SEQ ID NO:1, wherein the nucleotide sequence is a ribonucleic acid and the contacting occurs under the stringent conditions; and b) detecting whether hybridization occurs between the nucleic acid probe and the sample, wherein detection of said hybridization indicates that the sample expresses human CRABP-II.
Claim 11
Dependent Claim
13 words
The method of claim 7, further comprising quantifying the amount of the hybridization.
Claim 12
Dependent Claim
37 words
A vector comprising a nucleic acid which hybridizes under stringent conditions with either the nucleotide sequence set forth as SEQ ID NO:1 or the full length complement of the nucleotide sequence set forth as SEQ ID NO:1.
Claim 13
Dependent Claim
37 words
A vector comprising a nucleic acid which hybridizes under stringent conditions with either the nucleotide sequence set forth as SEQ ID NO:1 or the full length complement of the nucleotide sequence set forth as SEQ ID NO:1.
Claim 14
Dependent Claim
19 words
The vector of claim 9, wherein the nucleic acid has the nucleotide sequence set forth as SEQ ID NO:1.
Claim 15
Dependent Claim
29 words
The vector of claim 9, wherein the nucleic acid has the nucleotide sequence which is the full length complement to the nucleotide sequence set forth as SEQ ID NO:1.
Claim 16
Dependent Claim
14 words
An isolated nucleic acid comprising the nucleotide sequence set forth as SEQ ID NO:1.
Claim 17
Dependent Claim
14 words
An isolated nucleic acid comprising the nucleotide sequence set forth as SEQ ID NO:1.
Claim 18
Dependent Claim
19 words
An isolated nucleic acid comprising the full length complement of the nucleotide sequence set forth as SEQ ID NO:1.
Claim 19
Dependent Claim
19 words
An isolated nucleic acid comprising the full length complement of the nucleotide sequence set forth as SEQ ID NO:1.
References Cited (Backward Citations)
US4981784A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-02-15 | 2002-08-17 | 2003-02-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-02-15 | 2006-08-17 | 2007-02-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-02-15 | 2010-08-17 | 2011-02-16 | $7700.00 | Window Closed / Lapsed |